<SUBMISSION>
<ACCESSION-NUMBER>0000945836-01-500081
<TYPE>NT 10-K
<PUBLIC-DOCUMENT-COUNT>1
<PERIOD>20010930
<FILING-DATE>20011231
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>BIOZHEM COSMECEUTICALS INC
<CIK>0000774740
<ASSIGNED-SIC>5990
<IRS-NUMBER>760118305
<STATE-OF-INCORPORATION>TX
<FISCAL-YEAR-END>0930
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>NT 10-K
<ACT>34
<FILE-NUMBER>000-14725
<FILM-NUMBER>1826308
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>32238 PASEO ADELANTO
<STREET2>SUITE A
<CITY>SAN JUAN CAPISTRANO
<STATE>CA
<ZIP>92675
<PHONE>7144882183
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>32238 PASEO ADELANTO
<STREET2>STE A
<CITY>SAN JUAN CAPISTRANO
<STATE>CA
<ZIP>92675
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>ENTOURAGE INTERNATIONAL INC
<DATE-CHANGED>19920703
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>NT 10-K
<SEQUENCE>1
<FILENAME>form12b25-093001.txt
<DESCRIPTION>NT 10-K
<TEXT>
                SECURITIES AND EXCHANGE COMMISSION
                      WASHINGTON, DC 20549


                           FORM 12b-25


                              Commission File Number: 000-14725



                   NOTIFICATION OF LATE FILING

(Check One):
 [ x ] Form 10-K [   ] Form 20-F  [   ] Form 11-K
 [   ] Form 10-Q [   ] Form N-SAR

For Period Ended: September 30, 2001

[  ]  Transition Report on Form 10-K
[  ]  Transition Report on Form 10-Q
[  ]  Transition Report on Form 20-F
[  ]  Transition Report on Form N-SAR
[  ]  Transition Report on Form 11-K

For the Transition Period Ended:  N/A

NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE
COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.

If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
N/A


                 PART I.  REGISTRANT INFORMATION


Full name of registrant: BIOZHEM COSMECEUTICALS, INC.

Former name if applicable:  N/A

Address of principal executive office (Street and number):

25651 Atlantic Ocean Drive A-10

City, State and Zip Code:

Lake Forest, California 92630






                           Page 1 of 4

               Part II.  RULES 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to
Rule 12b-25(b), the following should be completed. (Check
appropriate box.)

[x]  (a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without unreasonable
effort or expense;

[x]  (b) The subject annual report, semi-annual report,
transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or
portion thereof will be filed on or before the 15th calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the
prescribed due date; and

[ ]  (c) The accountant's statement or other exhibit required
by Rule 12b-25(c) has been attached if applicable.

                       PART III. NARRATIVE

State below in reasonable detail the reasons why Form 10-K,
11-K, 20-F, 10-Q, N-SAR or the transition report or portion
thereof could not be filed within the prescribed time period.

                    SEE RIDER ANNEXED HERETO.

                   PART IV.  OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to
this notification:

                   Name: David M. Kaye
                   Area Code and Telephone number: 973-443-0600

(2) Have all other periodic reports required under Section 13
or 15(d) of the Securities Exchange Act of 1934 or Section 30
of the Investment Company Act of 1940 during the preceding 12
months (or for such shorter period that the registrant was
required to file such reports) been filed? If the answer is no,
identify report(s).
[ x ] Yes  [   ] No

(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be
included in the subject report or portion thereof?
[   ] Yes  [ x ] No

If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be
made.


                           Page 2 of 4


BIOZHEM COSMECEUTICALS, INC. has caused this notification to be
signed on its behalf by the undersigned thereunto duly
authorized.


Date: December 27, 2001  BY: /s/ Marti Wolf
                         Name: Marti Wolf
                         Title: President



                            ATTENTION

INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE
FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).



                         Page 3 of 4

BIOZHEM COSMECEUTICALS, INC.



RIDER TO FORM 12b-25


PART III - NARRATIVE

As a result of unexpected delays in gathering the data
necessary to finalize the Registrant's Form 10-KSB, largely due
to other necessary business commitments of certain of the
Registrant's officers responsible for preparing the subject
report, the Report on Form 10-KSB could not be timely filed
without unreasonable effort or expense.



                          Page 4 of 4

</TEXT>
</DOCUMENT>
</SUBMISSION>
